Durveqtix
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Durveqtix, covering 2024-05-31 to 2025-06-04. Get the full timeline:
Most recent: EMA Withdrawn: Beqvez (previously Durveqtix) (fidanacogene elaparvovec) — Pfizer Europe MA EEIG